Our Company

Our Company

Established in Europe in 2009, we are a multinational group that operates internationally and enjoys a strong presence in the major pharmaceutical markets. mAbxience is also fully committed [...]

About Us

About Us

Dr. Sigman and his biochemist wife, Silvia Gold, founded mAbxience in 2009 as the biotechnology arm of the CHEMO Group, which the couple set up in 1977. Hugo [...]

mAbBLOG

Differences between substitution and interchangeability

When a biosimilar drug is authorised by a regulatory agency, it means that it can be prescribed with guarantees over its efficacy and safety for all indications [...]

+